<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="2-part\PMC6789677\results\search\disease\results.xml">
  <result pre="Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Abstract Current seasonal" exact="influenza" post="A virus (IAV) vaccines are strain-specific and require annual"/>
  <result pre="often lead to high morbidity. Hence, development of a universal" exact="influenza" post="A vaccine targeting all IAV strains is urgently needed."/>
  <result pre="these results suggest that NvC-M2ex3 could be a potential universal" exact="influenza" post="A vaccine. universal influenza A vaccine Macrobrachium rosenbergii nodavirus"/>
  <result pre="NvC-M2ex3 could be a potential universal influenza A vaccine. universal" exact="influenza" post="A vaccine Macrobrachium rosenbergii nodavirus extracellular domain of matrix"/>
  <result pre="of highly pathogenic avian IAV to humans raised concerns of" exact="avian influenza" post="pandemics [2,3,4]. IAV is an enveloped virus with a"/>
  <result pre="highly pathogenic avian IAV to humans raised concerns of avian" exact="influenza" post="pandemics [2,3,4]. IAV is an enveloped virus with a"/>
  <result pre="are commonly used as the primary immunogenic components of current" exact="influenza" post="vaccines [5,6]. During a natural infection, HA binds to"/>
  <result pre="and NA reduce the efficacy of these antiviral drugs. Thus," exact="influenza" post="A vaccines have to be reformulated annually to counter"/>
  <result pre="rapidly mutating seasonal IAV [10]. The protective efficacy of current" exact="influenza" post="A vaccines varies between 60% to 90% depending on"/>
  <result pre="event of an unanticipated pandemic caused by genetic reassortments, seasonal" exact="influenza" post="vaccines become less effective, in addition to the considerable"/>
  <result pre="strains is urgently needed for the development of a universal" exact="influenza" post="A vaccine. The matrix 2 (M2) protein of IAV"/>
  <result pre="representing a potential candidate for the development of a universal" exact="influenza" post="A vaccine [14]. Unlike HA and NA, the M2e"/>
  <result pre="infection, or vaccination with the whole inactivated or live attenuated" exact="influenza" post="A vaccine, no notable M2e-specific antibody titer could be"/>
  <result pre="of M2e, various virus-like particles (VLPs) such as those of" exact="hepatitis" post="B virus (HBV), human papilloma virus (HPV), papaya mosaic"/>
  <result pre="RNA-phages Qβ and AP205, were shown to induce carrier-induced epitopic" exact="suppression" post="(CIES) in mice, a condition that is characterized by"/>
  <result pre="(CIES) in mice, a condition that is characterized by the" exact="suppression" post="of humoral immune responses directed against the target antigen"/>
  <result pre="these results demonstrated that NvC-M2ex3 could be a potential universal" exact="influenza" post="A vaccine. 2. Materials and Methods 2.1. Ethics Statement"/>
  <result pre="challenged with H1N1 (Figure 5(Ai)) but demonstrated a very mild" exact="bronchiolitis" post="when they were challenged with H3N2 (Figure 5(Bi)), suggesting"/>
  <result pre="of adjuvants [31]. In an attempt to produce a universal" exact="influenza" post="A vaccine, we previously constructed chimeric VLPs derived from"/>
  <result pre="the anti-M2e antibody was also reported to confer protection against" exact="influenza" post="virus infection via antibody-dependent cytotoxicity and antibody-mediated phagocytosis in"/>
  <result pre="a longer period of time [38]. In general, detection of" exact="influenza" post="viral RNA in the respiratory airway indicates the viral"/>
  <result pre="groups after being challenged with H1N1 or H3N2, suggesting the" exact="suppression" post="of viral shedding. The mice immunized with NvC-M2ex3 demonstrated"/>
  <result pre="the control groups. Positive correlation between IL-12 and IFN-γ in" exact="influenza" post="infection was also reported by Monteiro et al. [40]."/>
  <result pre="the peripheral blood mononuclear cells of patients infected with multidrug-resistant" exact="tuberculosis" post="and cord blood-derived mononuclear cells of neonates stimulated with"/>
  <result pre="of natural heterosubtypic protection, contrary to the current licensed inactivated" exact="influenza" post="vaccine which was reported to hamper the cross-protectivity of"/>
  <result pre="not reflect the risk of virus transmission in mice because" exact="influenza" post="A virus does not spread effectively in mice and"/>
  <result pre="antiviral cytokines could also potentially contribute to early protection against" exact="influenza" post="infections. Recommendations for future studies include investigation of the"/>
  <result pre="serum transfer, long-term protection, and challenges with different strains of" exact="influenza" post="A viruses. 6. Patent A patent entitled &quot;An Influenza"/>
  <result pre="ready?Biosecurity Bioterrorism Biodefense Strategy Pract. Sci.20053707310.1089/bsp.2005.3.70 2.LaiS.QinY.CowlingB.J.RenX.WardropN.A.GilbertM.TsangT.K.WuP.FengL.JiangH.et al.Global epidemiology of" exact="avian influenza" post="A H5N1 virus infection in humans, 1997–2015: A systematic"/>
  <result pre="Bioterrorism Biodefense Strategy Pract. Sci.20053707310.1089/bsp.2005.3.70 2.LaiS.QinY.CowlingB.J.RenX.WardropN.A.GilbertM.TsangT.K.WuP.FengL.JiangH.et al.Global epidemiology of avian" exact="influenza" post="A H5N1 virus infection in humans, 1997–2015: A systematic"/>
  <result pre="A systematic review of individual case dataLancet. Infect. Dis.201616e108e11810.1016/S1473-3099(16)00153-527211899 3.WongS.S.YuenK.Y.Avian" exact="influenza" post="virus infections in humansChest200612915616810.1378/chest.129.1.15616424427 4.YangY.HalloranM.E.SugimotoJ.D.LonginiI.M.Jr.Detecting human-to-human transmission of avian"/>
  <result pre="3.WongS.S.YuenK.Y.Avian influenza virus infections in humansChest200612915616810.1378/chest.129.1.15616424427 4.YangY.HalloranM.E.SugimotoJ.D.LonginiI.M.Jr.Detecting human-to-human transmission of" exact="avian influenza" post="A (H5N1)Emerg. Infect. Dis.2007131348135310.3201/eid1309.07011118252106 5.CoxN.J.SubbaraoK.InfluenzaLancet19993541277128210.1016/S0140-6736(99)01241-610520648 6.HouserK.SubbaraoK.Influenza Vaccines: Challenges and"/>
  <result pre="influenza virus infections in humansChest200612915616810.1378/chest.129.1.15616424427 4.YangY.HalloranM.E.SugimotoJ.D.LonginiI.M.Jr.Detecting human-to-human transmission of avian" exact="influenza" post="A (H5N1)Emerg. Infect. Dis.2007131348135310.3201/eid1309.07011118252106 5.CoxN.J.SubbaraoK.InfluenzaLancet19993541277128210.1016/S0140-6736(99)01241-610520648 6.HouserK.SubbaraoK.Influenza Vaccines: Challenges and"/>
  <result pre="basis of the structure and function of H1 hemagglutinin of" exact="influenza" post="virusProc. Jpn. Acad. Ser. B Phys. Biol. Sci.20128822624910.2183/pjab.88.226 9.BoltzD.A.AldridgeJ.R.WebsterR.G.GovorkovaE.A.Drugs"/>
  <result pre="Biol. Sci.20128822624910.2183/pjab.88.226 9.BoltzD.A.AldridgeJ.R.WebsterR.G.GovorkovaE.A.Drugs in Development for InfluenzaDrugs2010701349136210.2165/11537960-000000000-0000020614944 10.HussainM.GalvinH.D.HawT.Y.NutsfordA.N.HusainM.Drug resistance in" exact="influenza" post="A virus: The epidemiology and managementInfect. Drug Resist.20171012113410.2147/IDR.S10547328458567 11.ZhangX.S.PebodyR.De"/>
  <result pre="ectodomain of matrix protein 2Virol. J.2006310210.1186/1743-422X-3-10217150104 16.De FiletteM.RamneA.BirkettA.LyckeN.LowenadlerB.Min JouW.SaelensX.FiersW.The universal" exact="influenza" post="vaccine M2e-HBc administered intranasally in combination with the adjuvant"/>
  <result pre="particle vaccine with adjuvant protects mice against homologous and heterologous" exact="influenza" post="virusesVaccine2016346464647110.1016/j.vaccine.2016.11.02627866773 18.MaticS.RinaldiR.MasengaV.NorisE.Efficient production of chimeric human papillomavirus 16 L1"/>
  <result pre="of chimeric human papillomavirus 16 L1 protein bearing the M2e" exact="influenza" post="epitope in Nicotiana benthamiana plantsBMC Biotechnol.20111110610.1186/1472-6750-11-10622085463 19.DenisJ.Acosta-RamirezE.ZhaoY.HamelinM.E.KoukavicaI.BazM.AbedY.SavardC.PareC.Lopez MaciasC.et al.Development"/>
  <result pre="Nicotiana benthamiana plantsBMC Biotechnol.20111110610.1186/1472-6750-11-10622085463 19.DenisJ.Acosta-RamirezE.ZhaoY.HamelinM.E.KoukavicaI.BazM.AbedY.SavardC.PareC.Lopez MaciasC.et al.Development of a universal" exact="influenza" post="A vaccine based on the M2e peptide fused to"/>
  <result pre="vaccine platformVaccine2008263395340310.1016/j.vaccine.2008.04.05218511159 20.PetukhovaN.V.GasanovaT.V.StepanovaL.A.RusovaO.A.PotapchukM.V.KorotkovA.V.SkuratE.V.TsybalovaL.M.KiselevO.I.IvanovP.A.et al.Immunogenicity and protective efficacy of candidate universal" exact="influenza" post="A nanovaccines produced in plants by Tobacco mosaic virus-based"/>
  <result pre="Pharm Des.2013195587560010.2174/1381612811319999033723394564 21.HashemiH.PouyanfardS.BandehpourM.NoroozbabaeiZ.KazemiB.SaelensX.Mokhtari-AzadT.Immunization with M2e-displaying T7 bacteriophage nanoparticles protects against" exact="influenza" post="A virus challengePLoS ONE20127e4576510.1371/journal.pone.004576523029232 22.HerzenbergL.A.TokuhisaT.Epitope-specific regulation. I. Carrier-specific induction"/>
  <result pre="A virus challengePLoS ONE20127e4576510.1371/journal.pone.004576523029232 22.HerzenbergL.A.TokuhisaT.Epitope-specific regulation. I. Carrier-specific induction of" exact="suppression" post="for IgG anti-hapten antibody responsesJ. Exp. Med.19821551730174010.1084/jem.155.6.17306176665 23.JegerlehnerA.WieselM.DietmeierK.ZabelF.GattoD.SaudanP.BachmannM.F.Carrier induced"/>
  <result pre="for IgG anti-hapten antibody responsesJ. Exp. Med.19821551730174010.1084/jem.155.6.17306176665 23.JegerlehnerA.WieselM.DietmeierK.ZabelF.GattoD.SaudanP.BachmannM.F.Carrier induced epitopic" exact="suppression" post="of antibody responses induced by virus-like particles is a"/>
  <result pre="is a dynamic phenomenon caused by carrier-specific antibodiesVaccine2010285503551210.1016/j.vaccine.2010.02.10320307591 24.De FiletteM.MartensW.SmetA.SchotsaertM.BirkettA.Londono-ArcilaP.FiersW.SaelensX.Universal" exact="influenza" post="A M2e-HBc vaccine protects against disease even in the"/>
  <result pre="even in the presence of pre-existing anti-HBc antibodiesVaccine2008266503650710.1016/j.vaccine.2008.09.03818835315 25.De FiletteM.JouM.W.BirkettA.LyonsK.SchultzB.TonkyroA.ReschS.FiersW.Universal" exact="influenza" post="A vaccine: Optimization of M2-based constructsVirology200533714916110.1016/j.virol.2005.04.00415914228 26.YongC.Y.YeapS.K.HoK.L.OmarA.R.TanW.S.Potential recombinant vaccine"/>
  <result pre="A vaccine: Optimization of M2-based constructsVirology200533714916110.1016/j.virol.2005.04.00415914228 26.YongC.Y.YeapS.K.HoK.L.OmarA.R.TanW.S.Potential recombinant vaccine against" exact="influenza" post="A virus based on M2e displayed on nodaviral capsid"/>
  <result pre="28.ToapantaF.R.RossT.M.Impaired immune responses in the lungs of aged mice following" exact="influenza" post="infectionRespir. Res.20091011210.1186/1465-9921-10-11219922665 29.HopkinsM.J.MoorcroftJ.F.CorreiaJ.B.HartI.J.Using the full spectral capacity (six channels)"/>
  <result pre="pneumococcal pneumoniaPLoS ONE20138e5819110.1371/journal.pone.005819123483993 31.OngH.K.TanW.S.HoK.L.Virus like particles as a platform for" exact="cancer" post="vaccine developmentPeer J.20175e405310.7717/peerj.405329158984 32.NeirynckS.DerooT.SaelensX.VanlandschootP.JouW.M.FiersW.A universal influenza A vaccine based"/>
  <result pre="as a platform for cancer vaccine developmentPeer J.20175e405310.7717/peerj.405329158984 32.NeirynckS.DerooT.SaelensX.VanlandschootP.JouW.M.FiersW.A universal" exact="influenza" post="A vaccine based on the extracellular domain of the"/>
  <result pre="RooijenN.VerbeekS.FiersW.SaelensX.Universal vaccine based on ectodomain of matrix protein 2 of" exact="influenza" post="A: Fc receptors and alveolar macrophages mediate protectionJ. Immunol.20111861022103110.4049/jimmunol.090214721169548"/>
  <result pre="associated RNA promote T helper 1 type adaptive immunity against" exact="influenza" post="APLoS ONE20138e5908110.1371/journal.pone.005908123527091 35.SchotsaertM.YsenbaertT.NeytK.IbanezL.I.BogaertP.SchepensB.LambrechtB.N.FiersW.SaelensX.Natural and long-lasting cellular immune responses against"/>
  <result pre="influenza APLoS ONE20138e5908110.1371/journal.pone.005908123527091 35.SchotsaertM.YsenbaertT.NeytK.IbanezL.I.BogaertP.SchepensB.LambrechtB.N.FiersW.SaelensX.Natural and long-lasting cellular immune responses against" exact="influenza" post="in the M2e-immune hostMucosal. Immunol.2013627628710.1038/mi.2012.6922806098 36.WangB.Z.GillH.S.KangS.M.WangL.WangY.C.VassilievaE.V.CompansR.W.Enhanced influenza virus-like particle"/>
  <result pre="immune responses against influenza in the M2e-immune hostMucosal. Immunol.2013627628710.1038/mi.2012.6922806098 36.WangB.Z.GillH.S.KangS.M.WangL.WangY.C.VassilievaE.V.CompansR.W.Enhanced" exact="influenza" post="virus-like particle vaccines containing the extracellular domain of matrix"/>
  <result pre="and a Toll-like receptor ligandClin. Vaccine Immunol. CVI2012191119112510.1128/CVI.00153-1222647270 37.KillingleyB.Nguyen-Van-TamJ.Routes of" exact="influenza" post="transmissionInfluenza Other Respir. Viruses20137425110.1111/irv.12080 38.LeekhaS.ZitterkopfN.L.EspyM.J.SmithT.F.ThompsonR.L.SampathkumarP.Duration of influenza A virus"/>
  <result pre="CVI2012191119112510.1128/CVI.00153-1222647270 37.KillingleyB.Nguyen-Van-TamJ.Routes of influenza transmissionInfluenza Other Respir. Viruses20137425110.1111/irv.12080 38.LeekhaS.ZitterkopfN.L.EspyM.J.SmithT.F.ThompsonR.L.SampathkumarP.Duration of" exact="influenza" post="A virus shedding in hospitalized patients and implications for"/>
  <result pre="hospitalized with influenzaJ. Infect. Dis.200920049250010.1086/60038319591575 40.MonteiroJ.M.HarveyC.TrinchieriG.Role of interleukin-12 in primary" exact="influenza" post="virus infectionJ. Virol.199872482548319573248 41.HeX.S.DraghiM.MahmoodK.HolmesT.H.KembleG.W.DekkerC.L.ArvinA.M.ParhamP.GreenbergH.B.T cell-dependent production of IFN-gamma by"/>
  <result pre="cell-dependent production of IFN-gamma by NK cells in response to" exact="influenza" post="A virusJ. Clin. Investig.20041141812181910.1172/JCI2279715599406 42.WeissI.D.WaldO.WaldH.BeiderK.AbrahamM.GalunE.NaglerA.PeledA.IFN-gamma treatment at early stages"/>
  <result pre="A virusJ. Clin. Investig.20041141812181910.1172/JCI2279715599406 42.WeissI.D.WaldO.WaldH.BeiderK.AbrahamM.GalunE.NaglerA.PeledA.IFN-gamma treatment at early stages of" exact="influenza" post="virus infection protects mice from death in a NK"/>
  <result pre="cellsPediatric. Res.19974154755310.1203/00006450-199704000-00015 45.DienzO.RudJ.G.EatonS.M.LanthierP.A.BurgE.DrewA.BunnJ.SurattB.T.HaynesL.RinconM.Essential role of IL-6 in protection against H1N1" exact="influenza" post="virus by promoting neutrophil survival in the lungMucosal Immunol.2012525826610.1038/mi.2012.222294047"/>
  <result pre="47.PaquetteS.G.BannerD.ZhaoZ.FangY.HuangS.S.LeomicronnA.J.NgD.C.AlmansaR.Martin-LoechesI.RamirezP.et al.Interleukin-6 is a potential biomarker for severe pandemic H1N1" exact="influenza" post="A infectionPLoS ONE20127e3821410.1371/journal.pone.003821422679491 48.BodewesR.KreijtzJ.H.BaasC.Geelhoed-MierasM.M.de MutsertG.van AmerongenG.van den BrandJ.M.FouchierR.A.OsterhausA.D.RimmelzwaanG.F.Vaccination against"/>
  <result pre="A infectionPLoS ONE20127e3821410.1371/journal.pone.003821422679491 48.BodewesR.KreijtzJ.H.BaasC.Geelhoed-MierasM.M.de MutsertG.van AmerongenG.van den BrandJ.M.FouchierR.A.OsterhausA.D.RimmelzwaanG.F.Vaccination against human" exact="influenza" post="A/H3N2 virus prevents the induction of heterosubtypic immunity against"/>
  <result pre="prevents the induction of heterosubtypic immunity against lethal infection with" exact="avian influenza" post="A/H5N1 virusPLoS ONE20094e553810.1371/journal.pone.000553819440239 49.McKeeS.J.YoungV.L.ClowF.HaymanC.M.BairdM.A.HermansI.F.YoungS.L.WardV.K.Virus-like particles and alpha-galactosylceramide form a"/>
  <result pre="the induction of heterosubtypic immunity against lethal infection with avian" exact="influenza" post="A/H5N1 virusPLoS ONE20094e553810.1371/journal.pone.000553819440239 49.McKeeS.J.YoungV.L.ClowF.HaymanC.M.BairdM.A.HermansI.F.YoungS.L.WardV.K.Virus-like particles and alpha-galactosylceramide form a"/>
  <result pre="50.EdenboroughK.M.GilbertsonB.P.BrownL.E.A mouse model for the study of contact-dependent transmission of" exact="influenza" post="A virus and the factors that govern transmissibilityJ. Virol.201286125441255110.1128/JVI.00859-1222951824"/>
  <result pre="Figure 2 Mortality and morbidity of BALB/c mice after lethal" exact="influenza" post="A virus infections. Survival rate of mice infected with"/>
  <result pre="= 3) immunized with the chimeric proteins and challenged with" exact="influenza" post="A virus H1N1 or H3N2. (A) The lungs of"/>
  <result pre="as (a), (b), and (c). Dashed and solid arrows indicate" exact="bronchiolitis" post="and interstitial inflammation respectively, and triangles indicate edema, n"/>
  <result pre="inflammatory scores of the mice (n = 3) challenged with" exact="influenza" post="A virus. A lower lung inflammatory score was observed"/>
 </snippets>
</snippetsTree>
